Related Experiment Videos

Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections

J Focht1, S H Hansen, J V Nielsen

  • 1Bioscientia, Institute for Laboratory Medicine, Moers, Fed. Rep. of Germany.

Arzneimittel-Forschung
|August 1, 1993
PubMed

Insights

This study shows propolis, a bee product, has a bactericidal effect against upper respiratory tract infection strains. This supports its use in natural medicine for colds and inflammation.

Area of Science:

  • Natural Products Research
  • Microbiology
  • Pharmacology

Background:

  • Propolis is a resinous mixture produced by honeybees.
  • It is known for its diverse biological activities, including antimicrobial properties.
  • Traditional medicine utilizes propolis for various ailments, including respiratory conditions.

Purpose of the Study:

  • To investigate the bactericidal efficacy of propolis.
  • To determine its effect on bacterial strains isolated from upper respiratory tract infections.
  • To evaluate propolis as a therapeutic agent for common colds and inflammatory processes.

Main Methods:

  • Isolation of bacterial strains from patients with upper respiratory tract infections.
  • In vitro testing of propolis extracts against these bacterial strains.
  • Assessment of bactericidal activity through appropriate microbiological assays.

Main Results:

  • Propolis demonstrated a significant bactericidal effect against tested bacterial strains.
  • The efficacy was observed against multiple strains relevant to upper respiratory tract infections.
  • Results indicate a direct antimicrobial action of propolis.

Conclusions:

  • Propolis exhibits a demonstrable bactericidal effect on pathogens causing upper respiratory tract infections.
  • This finding supports the traditional use of propolis in natural medicine for managing common colds and inflammation.
  • Further research into propolis-based therapies for respiratory infections is warranted.

Related Concept Videos